Home - Products - Others - Other Targets - Loganic acid 6′-O-β-D-glucoside

Loganic acid 6′-O-β-D-glucoside

CAS No. 176226-39-4

Loganic acid 6′-O-β-D-glucoside( 8-Epi-Loganic acid-6'-O-β-D-glucoside )

Catalog No. M29256 CAS No. 176226-39-4

8-Epi-Loganic acid-6'-O-β-D-glucoside is a natural product from Cistanche deserticola Ma.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 459 In Stock
10MG 657 In Stock
25MG 1026 In Stock
50MG 1349 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Loganic acid 6′-O-β-D-glucoside
  • Note
    Research use only, not for human use.
  • Brief Description
    8-Epi-Loganic acid-6'-O-β-D-glucoside is a natural product from Cistanche deserticola Ma.
  • Description
    8-Epi-Loganic acid-6'-O-β-D-glucoside is a natural product from Cistanche deserticola Ma.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    8-Epi-Loganic acid-6'-O-β-D-glucoside
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    176226-39-4
  • Formula Weight
    538.499
  • Molecular Formula
    C22H34O15
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C[C@H]1[C@@H](O)C[C@H]2[C@@H]1[C@H](O[C@@H]1O[C@H](CO[C@@H]3O[C@H](CO)[C@@H](O)[C@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]1O)OC=C2C(O)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Granuliberin R

    Granuliberin R is a new mast cell degranulating peptide comes from amphibian, can be isolated from the skin of frog Rana rugosa. Granuliberin R is a dodecapeptide, can act on rat peritoneal mast cell to liberate granules and release histamine.

  • GSK484 hydrochloride

    GSK484 hydrochloride (GTPL8577) is a specifc and reversible peptidyl arginine deiminase 4 (PAD4) inhibitor.

  • Etrolizumab

    Etrolizumab (rhuMAb Beta7), a gut-selective anti-β7 integrin monoclonal antibody, targets the β7 subunit of α4β7 and αEβ7 integrins specifically, demonstrating affinity with K i values of 18 nM for Human α4β7 and 1800 pM for Human αEβ7-293.